Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy (NYSE:PFE)

Group 1 - The article discusses the performance and outlook of Pfizer Inc. (PFE), indicating a bullish sentiment towards the stock based on its competitive advantages and defensibility in the market [1] - The analysis focuses on high-quality companies that can outperform the market over the long term, emphasizing the importance of an economic moat [1] - The research is primarily centered on European and North American companies, without restrictions on market capitalization, covering both large-cap and small-cap firms [1]